Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 962 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Modest Population-Level Increases in Survival Observed After Implementation of Immune Checkpoint... February 1, 2023 Gilteritinib Improves Survival in AML with FLT3 Mutations November 27, 2019 Help seeking: Why isn’t it as simple as it might sound? August 10, 2022 Abemaciclib Improves PFS at Six Months Among Patients with High-Grade Meningiomas... January 26, 2026 Load more HOT NEWS Molecular Analysis for Precision Oncology Congress 2025, Paris, France, 15-16 September FDA Approves Brexucabtagene Autoleucel for Relapsed or Refractory B-Cell Precursor Acute... Mom Wants Disney To Ban Childless Adults From Their Theme Parks One Dose of Either a Bivalent or Nonavalent HPV Vaccine Provides...
